Surgery Partners Inc (NASDAQ:SGRY) price on current trading day, fall -4.71% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $21.46.
A look at the stock’s price movement, the close in the last trading session was $22.52, moving within a range at $21.1 and $22.7. The beta value (5-Year monthly) was 2.766. Turning to its 52-week performance, $36.92 and $21.36 were the 52-week high and 52-week low respectively. Overall, SGRY moved -27.79% over the past month.
Surgery Partners Inc’s market cap currently stands at around $2.73 billion, with investors looking forward to this quarter’s earnings report slated for in January.
Analysts have a consensus estimate of 828.08M for the company’s revenue for the quarter, with a low and high estimate of 824.8M and 839.2M respectively. The average forecast suggests up to a 12.60% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 3.08B, representing a 12.20% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that SGRY is a 100% Sell. On the other hand, the stock is on average a Hold as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
8 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 3 analyst(s) rate the stock as a Hold, 5 recommend SGRY as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
SGRY’s current price about -12.90% and -24.38% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 29.42, while 7-day volatility ratio is 5.03% and 6.25% in the 30-day chart. Further, Surgery Partners Inc (SGRY) has a beta value of 2.58, and an average true range (ATR) of 1.34. Analysts have given the company’s stock an average 52-week price target of $34.5, forecast between a low of $31 and high of $40. Looking at the price targets, the low is -44.45% off current price level while to achieve the yearly target high, price needs to move -86.39%. Nonetheless, investors will most likely welcome a -60.76% jump to $34.5 which is the analysts’ median price.
If we refocus on Surgery Partners Inc (NASDAQ:SGRY), historical trading data shows that trading volumes averaged 1.17 over the past 10 days and 918.61K over the past 3 months. The company’s latest data on shares outstanding shows there are 127.13 million shares.
The 41.80% of Surgery Partners Inc’s shares are in the hands of company insiders while institutional holders own 68.04% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 10.07 million on 2024-11-15, giving us a short ratio of 10.96. The data shows that as of 2024-11-15 short interest in Surgery Partners Inc (SGRY) stood at 1744.0000000000002 of shares outstanding, with shares short falling to 10.12 million registered in 2024-10-15. Current price change has pushed the stock -32.92% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the SGRY stock continues to rise going into the next quarter.
